Does Rallies track congressional trades in WAT?

Yes. Rallies tracks politician and congressional stock disclosures for WAT, including reported purchases, sales, dates, owners, and trade amounts when available.

Is WAT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WAT. It does not provide personalized investment advice.

WAT (Waters Corp) Stock Analysis - Politician Trades

Waters Corp (WAT) is a publicly traded Healthcare sector company. As of May 21, 2026, WAT trades at $341.36 with a market cap of $32.62B and a P/E ratio of 31.62. WAT moved +2.35% today. Year to date, WAT is -13.58%; over the trailing twelve months it is -5.74%. Its 52-week range spans $275.05 to $423.56. Analyst consensus is buy with an average price target of $375.59. Rallies surfaces WAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded WAT stock?

Recent politician trading activity in WAT includes disclosures from Thomas H. Kean, Thomas H. Kean, Debbie Dingell, Kevin Hern, and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

WAT Key Metrics

Key financial metrics for WAT
Metric	Value
Price	$341.36
Market Cap	$32.62B
P/E Ratio	31.62
EPS	$10.80
Dividend Yield	0.00%
52-Week High	$423.56
52-Week Low	$275.05
Volume	4
Avg Volume	0
Revenue (TTM)	$3.17B
Net Income	$642.63M
Gross Margin	59.28%

Congressional Trades in WAT

Thomas H. Kean sale WAT on Mar 10, 2026 (amount: $15.00K).
Thomas H. Kean sale WAT on Feb 13, 2026 (amount: $15.00K).
Debbie Dingell receive WAT on Feb 10, 2026 (amount: $15.00K).
Kevin Hern exchange WAT on Feb 9, 2026 (amount: $15.00K) for Joint.
Gilbert Cisneros purchase WAT on Sep 30, 2025 (amount: $15.00K).

Latest WAT News

Waters Corporation Q1 EPS $2.70 and $1.27B Revenue Spur UBS to Raise Target to $375 — May 6, 2026
Waters jumps as investors focus on Q1 results and BD integration milestones — May 5, 2026
Waters jumps 5% as Evercore upgrade fuels pre-earnings bid into May 5 results — Apr 30, 2026
Waters drops ahead of Q1 earnings as BD integration worries linger — Apr 29, 2026
Waters falls as BD Life Sciences integration risk and near-term outlook weigh — Apr 27, 2026

Recent WAT Insider Trades

Jiang Wei bought 500 (~$144.73K) on Mar 16, 2026.
FEARON RICHARD H bought 1.00K (~$306.34K) on Mar 6, 2026.

WAT Analyst Consensus

15 analysts cover WAT: 0 strong buy, 7 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $375.59.

Common questions about WAT

Which politicians traded WAT stock?: Recent politician trading activity in WAT includes disclosures from Thomas H. Kean, Thomas H. Kean, Debbie Dingell, Kevin Hern, and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in WAT?: Yes. Rallies tracks politician and congressional stock disclosures for WAT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is WAT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WAT. It does not provide personalized investment advice.